Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

blank

 

Recent News and Articles on the Keywords: discusses early + early stage + biomoda  Related to the article below (Last Update: 7/1/2008)

An Expert Interview With Ferdinand C. Breedveld, MD, PhD
Medscape (subscription) -
Therefore, in Europe there is access to clinical practice data from early-stage RA, data that will be of immense value to the ACR. With new clinical data, ...
Stem cell research from an ethical point of view
News-Medical.net, Australia -
Moreover the book discusses several sub-problems strongly related to this topic, ie when does any individual human being begin or at what stage development ...
Tew discusses player drain that's become a torrent
SundayNews.co.nz, New Zealand - Jun 28, 2008
SN: It has been speculated that there could be changes to the Super 14 and Tri-nations as early as next year. Is this likely? ST: Personally, I think change ...
Mt. Orab Mayor discusses possible plans for park
Georgetown News Democrat, OH - Jun 25, 2008
"Adding a stage was just an idea I had." The project is still in the very early preliminary stages and Lunsford said cost estimates and feasibility studies ...
Why I No Longer Date Porn Stars, plus Rock & Roll Comics: The ...
San Diego Reader, CA -
She did several early Carnal Comics and many feel, myself included, that her feminine style set the tone for the entire line - sexy stories told from a ...
Free Kennedy Center tour is just the ticket
Cape Cod Times, MA - Jun 28, 2008
Go as early as possible on the weekends since certain theaters close for matinees. During the week, later is better. Tour the center, find happy hour deals ...
(#pharyngula on irc.synirc.net)
ScienceBlogs - Jun 26, 2008
Vertebrates do not do this, or do so to a much lesser degree; we have regulative development, in which early cells are much more plastic, and gradually and ...
Key Bengals' questions: Johnson's ankle, behavior - NFL
ESPN - Jun 25, 2008
It appears at this early stage that Rivers is playing his way into a starting outside linebacker role. James Walker covers the NFL for ESPN.com. ...

New York Times
Clinton Discusses What She Wants, but Not What She Will Do
New York Times, United States - Jun 4, 2008
More Photos > By KATE ZERNIKE Senator Hillary Rodham Clinton took the stage before supporters Tuesday night and finally asked the question that so many ...
'When I walk out on a stage, I try to be in the moment'
San Diego Union Tribune, United States - Jun 12, 2008
For Hancock, who won his first Grammy in 1983, the number of heads and hearts has grown exponentially since early February. ...
Source: Google News

… setting and the unique checking constraint: A new explanation of the optional infinitive stage -
K Wexler - Lingua, 1998 - Elsevier
... outline some of the central properties of the 01 stage without providing any kind
of detailed coverage. Section 3 discusses Very Early Parameter-Setting (VEPS ...

Treatment Decision Making in Early-Stage Breast Cancer: Should Surgeons Match Patients' Desired … -
NL Keating, E Guadagnoli, MB Landrum, C Borbas, JC … - Journal of Clinical Oncology, 2002 - jco.ascopubs.org
... patients (64%) desired a collaborative role where "the doctor discusses alternatives
with ... al: The quality of care for treatment of early stage breast carcinoma ...

[BOOK] Developing Support Groups for Individuals with Early-Stage Alzheimer's Disease: Planning, …
R Yale - 1995 - Health Professions Pr

Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer -
Y Hayata - Chest, 1984 - Am Coll Chest Phys
... derivative in early and stage 1 lung cancer Photoradiation therapy with hematoporphyrin ...
body weight. Eight of the 13 early-stage cases were treated ...

Early Diagnosis of MIS Implementation Failure: Promising Results and Unanswered Questions
MJ Ginzberg - Management Science, 1981 - JSTOR
... 19], in his review of this literature, discusses some of the ... be necessary to measure
them at an earlier stage of the ... It remains to be determined how early in a ...

Interactive sketching for the early stages of user interface design -
JA Landay, BA Myers - Proceedings of the SIGCHI conference on Human factors in …, 1995 - portal.acm.org
... At each stage of the process the interface can ... several drawbacks when used in the
early stages of ... design and problem-solving literature discusses drawing rough ...

The role of conceptual frameworks in epidemiological analysis: a hierarchical approach -
CG Victora - International Journal of Epidemiology, 1997 - IEA
... The present paper discusses appropriate data analysis strategies for assessing disease ...
At an early stage in the planning of an epidemio- logical study one ...

… hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: Detection … -
TF Wood, DT Nora, DL Morton, RR Turner, D Rangel, … - Journal of Gastrointestinal Surgery, 2002 - Springer
... in CRC performed at the John Wayne Cancer Institute and discusses impor- tant ... Technical
details of in- traoperative lymphatic mapping for early stage melanoma. ...

… flow and two-pion correlations from a relativistic hydrodynamic model with early chemical freeze-out -
T Hirano, K Tsuda - Physical Review C, 2002 - APS
... When one discusses the spectral changes of hadrons due to the medium effects ... useful
comments and K. Kajimoto for his collaboration in the early stage of this ...

Bubble growth and droplet decay in the quark-hadron phase transition in the early Universe -
K Kajantie, H Kurki-Suonio - Physical Review D, 1986 - APS
... a reference value Ri1= m so that XRi 10-4. Section VI discusses what can ... The bubble
configuration (a) of the early stage of the phase transition changes to a ...

Source: Google Scholar

Biomoda Discusses TCPP Technology For Early Stage Cancer Detection

Biomoda, Inc. (OTC Bulletin Board: BMOD) today issued an in-depth discussion of its patented, early-stage cancer detection technology.

In 1992 Biomoda exclusively licensed the TCPP patent from Los Alamos National Laboratories (LNAL) for lung cancer diagnosis and treatment.

Since then the company has initiated internal and external testing of TCPP on various cancers and expanded known their research into what is called the CyPath Lung Cancer Assay.
Tetrakis Carboxy Phenyl Porphine (TCPP) is a porphyrin that binds to cancer cells. Porphyrins are naturally occurring pigments that fluoresce red when exposed to UV light.

TCPP has been shown to bind to cancerous and precancerous cells in both patient samples and tissue cultures.

Biomoda has optimized the labeling solution, known as CyPath, for lung cancer detection so that a maximum color differential between TCPP exposed cancer cells and normal cells exists. Simply put, a cancer cell will appear bright red while other types of cells will appear white/green under a microscope with UV light.

Even in the earliest studies conducted, TCPP consistently identified pre-cancerous and cancer cells in patient samples.

In 1992, LANL and St. Mary's Hospital conducted a pilot study using sputum (phlegm) samples from 12 uranium miners. PAP analysis had shown that eight of the 12 miners had lung cancer. LANL did a blind TCPP analysis of the 12 samples and correctly identified the eight lung cancer patients. The LANL study also identified one of the samples from a patient without lung cancer as positive. Further analysis of that same sample showed that the patient was misdiagnosed by the PAP analysis and did indeed have lung cancer.

In 1998, LungCheck conducted a study for Biomoda. For this study, LungCheck used 52 samples from patients with dysplasia, carcinoma in situ (CIS) and lung cancer (adenocarcinoma, squamous cell carcinoma, small cell carcinoma) and seven samples from patients with metaplasia as "controls." The sensitivity, a measurement of accuracy, for this study was calculated at 96.2 percent.
In addition to Independent Validation Studies currently underway, Biomoda is simultaneously conducting an internal validation study using prospective samples collected from clinical sites in the US and Russia.

Biomoda's findings indicate that this assay can be used to distinguish cancer patients from controls and to distinguish smokers from controls and cancer patients.

Although the company is concentrating its efforts on early detection of lung cancer, studies have lead to an indication that there may be several other potential applications for the TCPP technology, such as cervical cancer based on cervical swab samples, breast cancer based on ductal lavage samples, and bladder cancer based on urine samples. In addition, Leukemia could potentially be diagnosed with TCPP labeling solution, CyPath, using blood or bone marrow. There is also the potential to use CyPath for histological examination of biopsy samples for all cancers. There are three commonly used techniques for preparing slides for cytology examination. Biomoda has qualified CyPath with each of these techniques.

Biomoda has exclusively licensed one patent from Los Alamos National Laboratories (LANL). The patent (US Patent Number: 5,162,231) is for the use of TCPP and other porphyrins as fluorescence tracers for cancer cells. In addition, Biomoda has received (US Patent Number: 6,838,248) for methods of detecting pre-cancerous and cancerous cells using TCPP. The company has three other patents filed and pending.

About Biomoda, Inc.

Biomoda, Inc. (OTC Bulletin Board: BMOD), is a biopharmaceutical company focusing on early cancer detection technology. Biomoda's non-invasive, cell-targeting technology is globally patented for the detection of pre-cancerous and cancerous conditions in all human tissue. This technology, based on a compound called Tetrakis Carboxy Phenyl Porphine (TCPP), was developed at Los Alamos National Laboratories. Biomoda obtained a worldwide exclusive license to the TCPP technology from Los Alamos National Laboratories, and began new research broadening the scope of the original patent and technology. For more information about Biomoda, please visit the company's website at http://www.biomoda.com.

Forward Looking Statements:

This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. Forward-looking statements include, without limitation, our ability to increase income streams, to grow revenue and earnings, and to obtain additional patents and strategic partnerships or research projects. These statements are only predictions and are subject to certain risks, uncertainties and assumptions, which are identified and described in the Company's public filings with the Securities and Exchange Commission.

Biomoda, Inc.
http://www.biomoda.com
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.